HC Wainwright Reaffirms “Buy” Rating for Tango Therapeutics (NASDAQ:TNGX)
HC Wainwright restated their buy rating on shares of Tango Therapeutics (NASDAQ:TNGX – Free Report) in a report published on Monday morning, Benzinga reports. They currently have a $13.00 target price on the stock. A number of other research firms have also recently commented on TNGX. Jefferies Financial Group assumed coverage on Tango Therapeutics in […]
More Stories
Terrance Mcguire Sells 119,805 Shares of Invivyd, Inc. (NASDAQ:IVVD) Stock
Invivyd, Inc. (NASDAQ:IVVD – Get Free Report) Director Terrance Mcguire sold 119,805 shares of the firm’s stock in a transaction...
Michael Sentonas Sells 10,801 Shares of CrowdStrike Holdings, Inc. (NASDAQ:CRWD) Stock
CrowdStrike Holdings, Inc. (NASDAQ:CRWD – Get Free Report) President Michael Sentonas sold 10,801 shares of the company’s stock in a...
Short Interest in Themes Global Systemically Important Banks ETF (NASDAQ:GSIB) Expands By 300.0%
Themes Global Systemically Important Banks ETF (NASDAQ:GSIB – Get Free Report) saw a large growth in short interest in December....
Nuveen Multi-Market Income Fund (NYSE:JMM) Short Interest Up 333.3% in December
Nuveen Multi-Market Income Fund (NYSE:JMM – Get Free Report) was the target of a large increase in short interest in...
Short Interest in First Trust Municipal High Income ETF (NASDAQ:FMHI) Rises By 353.9%
First Trust Municipal High Income ETF (NASDAQ:FMHI – Get Free Report) was the recipient of a significant growth in short...
Exchange Bank (Santa Rosa, CA) (OTCMKTS:EXSR) Short Interest Up 400.0% in December
Exchange Bank (Santa Rosa, CA) (OTCMKTS:EXSR – Get Free Report) was the recipient of a large increase in short interest...